Back to Investors

Crescendo Real Estate Advisors

Evidence PackPROIndependent
Real EstateLOS ANGELES, CA, UK Website
AUM
$387M
Ownership
independent
Stakeability
33 / VERY LOW
Priority
Tier
Employees
2

Crescendo Real Estate Advisors specializes in acquiring and managing real estate assets through private equity investments.

SEC RegisteredFund PerformanceBDC ExposureTeam DataRegulatory

Coverage

42%

Adaptive profile: standard

Signals present
5/12
SEC / ADVFund Performance(50)BDC Exposure(1)13F Holders(0)Team(30)ILS Deals(0)Regulatory(13)Legal(0)Lobbying(0)Hiring(0)News(0)GP Stakes Deals(0)

Data Freshness

Recent Changes

Stakeability Breakdown

33 / 100
Fund PerformanceAUM growth and fundraising track record
37
Team StabilityLeadership continuity and key person risk
10
Market PositionBrand strength and competitive positioning
33
Succession ReadinessNext-gen leadership and governance structure
60
Transaction FeasibilityLikelihood of a stake transaction
22
Unable to load signal breakdown.

IC Risk Memo

PRO

Investment committee-ready memo with risk analysis and recommendation

Click "Generate Memo" to create an IC-ready analysis

Includes risk factors, citations, and recommendation

CRD Number
309932
SEC File Number
801-121844
Registration Type
Registered
Filing Date
Dec 3, 2025
Employee Count
30
Discretionary AUM
$459.6M
Private Funds
5
PE Funds
N/A
VC Funds
N/A
RE Funds
5
Hedge Funds
N/A
Gross Assets (Private)
$468.0M
Source: SEC IAPD

Fund performance data requires Professional

Upgrade your plan to access this section.

Upgrade

BDC exposure data requires Professional

Upgrade your plan to access this section.

Upgrade

Team data requires Professional

Upgrade your plan to access this section.

Upgrade

Team intelligence requires Professional

Upgrade your plan to access this section.

Upgrade

Competition mapping requires Professional

Upgrade your plan to access this section.

Upgrade

Regulatory data requires Professional

Upgrade your plan to access this section.

Upgrade

No GP stakes deals recorded

This GP has not sold a minority stake, making it a potential target.